Literature DB >> 17347654

CUE domain containing 2 regulates degradation of progesterone receptor by ubiquitin-proteasome.

Pei-Jing Zhang1, Jie Zhao, Hui-Yan Li, Jiang-Hong Man, Kun He, Tao Zhou, Xin Pan, Ai-Ling Li, Wei-Li Gong, Bao-Feng Jin, Qing Xia, Ming Yu, Bei-Fen Shen, Xue-Min Zhang.   

Abstract

Accumulated evidence indicates that progesterone receptors (PR) are involved in proliferation of breast cancer cells and are implicated in the development of breast cancer. In this paper, a yeast two-hybrid screen for PR led to the identification of CUE domain containing 2 (CUEDC2), whose function is unknown. Our results demonstrate that CUEDC2 interacts with PR and promotes progesterone-induced PR degradation by the ubiquitin-proteasome pathway. The inhibition of endogenous CUEDC2 by siRNA nearly abrogated the progesterone-induced degradation of PR, suggesting that CUEDC2 is involved in progesterone-induced PR ubiquitination and degradation. Moreover, we identify the sumoylation site Lys-388 of PR as the target of CUEDC2-promoted ubiquitination. CUEDC2 decreases the sumoylation while promoting ubiquitination on Lys-388 of PRB. We also show that CUEDC2 represses PR transactivation, inhibits the ability of PR to stimulate rapid MAPK activity, and impairs the effect of progesterone on breast cancer cell growth. Therefore, our results identify a key post-translational mechanism that controls PR protein levels and for the first time provide an important insight into the function of CUEDC2 in breast cancer proliferation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17347654      PMCID: PMC1847652          DOI: 10.1038/sj.emboj.7601602

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  43 in total

Review 1.  Nuclear receptor coactivators: multiple enzymes, multiple complexes, multiple functions.

Authors:  N J McKenna; J Xu; Z Nawaz; S Y Tsai; M J Tsai; B W O'Malley
Journal:  J Steroid Biochem Mol Biol       Date:  1999 Apr-Jun       Impact factor: 4.292

2.  SUMO-1 modification of Mdm2 prevents its self-ubiquitination and increases Mdm2 ability to ubiquitinate p53.

Authors:  T Buschmann; S Y Fuchs; C G Lee; Z Q Pan; Z Ronai
Journal:  Cell       Date:  2000-06-23       Impact factor: 41.582

3.  Ubc9 interacts with SOX4 and represses its transcriptional activity.

Authors:  Xin Pan; Huiyan Li; Peijing Zhang; Baofeng Jin; Jianghong Man; Lifeng Tian; Guiying Su; Jie Zhao; Weihua Li; Hui Liu; Weili Gong; Tao Zhou; Xuemin Zhang
Journal:  Biochem Biophys Res Commun       Date:  2006-04-17       Impact factor: 3.575

4.  Phosphorylation of human progesterone receptors at serine-294 by mitogen-activated protein kinase signals their degradation by the 26S proteasome.

Authors:  C A Lange; T Shen; K B Horwitz
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

5.  Progesterone receptors induce cell cycle progression via activation of mitogen-activated protein kinases.

Authors:  Andrew Skildum; Emily Faivre; Carol A Lange
Journal:  Mol Endocrinol       Date:  2004-10-14

6.  The activity of a human endoplasmic reticulum-associated degradation E3, gp78, requires its Cue domain, RING finger, and an E2-binding site.

Authors:  Bo Chen; Jennifer Mariano; Yien Che Tsai; Anna H Chan; Mickael Cohen; Allan M Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-03       Impact factor: 11.205

7.  SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation.

Authors:  J M Desterro; M S Rodriguez; R T Hay
Journal:  Mol Cell       Date:  1998-08       Impact factor: 17.970

Review 8.  Coactivators and corepressors as mediators of nuclear receptor function: an update.

Authors:  G Jenster
Journal:  Mol Cell Endocrinol       Date:  1998-08-25       Impact factor: 4.102

Review 9.  The SRC family of nuclear receptor coactivators.

Authors:  C Leo; J D Chen
Journal:  Gene       Date:  2000-03-07       Impact factor: 3.688

10.  PIAS3 induction of PRB sumoylation represses PRB transactivation by destabilizing its retention in the nucleus.

Authors:  Jiang-Hong Man; Hui-Yan Li; Pei-Jing Zhang; Tao Zhou; Kun He; Xin Pan; Bing Liang; Ai-Ling Li; Jie Zhao; Wei-Li Gong; Bao-Feng Jin; Qing Xia; Ming Yu; Bei-Fen Shen; Xue-Min Zhang
Journal:  Nucleic Acids Res       Date:  2006-10-04       Impact factor: 16.971

View more
  37 in total

1.  Mechanisms underlying the control of progesterone receptor transcriptional activity by SUMOylation.

Authors:  Hany Abdel-Hafiz; Michelle L Dudevoir; Kathryn B Horwitz
Journal:  J Biol Chem       Date:  2009-02-11       Impact factor: 5.157

2.  Dual modification of BMAL1 by SUMO2/3 and ubiquitin promotes circadian activation of the CLOCK/BMAL1 complex.

Authors:  Jiwon Lee; Yool Lee; Min Joo Lee; Eonyoung Park; Sung Hwan Kang; Chin Ha Chung; Kun Ho Lee; Kyungjin Kim
Journal:  Mol Cell Biol       Date:  2008-07-21       Impact factor: 4.272

3.  A CUE hints at tumor resistance.

Authors:  Christoforos Thomas; Jan-Ake Gustafsson
Journal:  Nat Med       Date:  2011-06       Impact factor: 53.440

Review 4.  Progesterone action in breast, uterine, and ovarian cancers.

Authors:  Caroline H Diep; Andrea R Daniel; Laura J Mauro; Todd P Knutson; Carol A Lange
Journal:  J Mol Endocrinol       Date:  2015-01-13       Impact factor: 5.098

5.  Elevated expression of CUEDC2 protein confers endocrine resistance in breast cancer.

Authors:  Xin Pan; Tao Zhou; Yan-Hong Tai; Chenguang Wang; Jie Zhao; Yuan Cao; Yuan Chen; Pei-Jing Zhang; Ming Yu; Cheng Zhen; Rui Mu; Zhao-Fang Bai; Hui-Yan Li; Ai-Ling Li; Bing Liang; Zhao Jian; Wei-Na Zhang; Jiang-Hong Man; Yan-Fei Gao; Wei-Li Gong; Li-Xin Wei; Xue-Min Zhang
Journal:  Nat Med       Date:  2011-05-15       Impact factor: 53.440

Review 6.  Post-translational modifications of the progesterone receptors.

Authors:  Hany A Abdel-Hafiz; Kathryn B Horwitz
Journal:  J Steroid Biochem Mol Biol       Date:  2013-12-12       Impact factor: 4.292

7.  Cdk1-phosphorylated CUEDC2 promotes spindle checkpoint inactivation and chromosomal instability.

Authors:  Yan-Fei Gao; Teng Li; Yan Chang; Yu-Bo Wang; Wei-Na Zhang; Wei-Hua Li; Kun He; Rui Mu; Cheng Zhen; Jiang-Hong Man; Xin Pan; Tao Li; Liang Chen; Ming Yu; Bing Liang; Yuan Chen; Qing Xia; Tao Zhou; Wei-Li Gong; Ai-Ling Li; Hui-Yan Li; Xue-Min Zhang
Journal:  Nat Cell Biol       Date:  2011-07-10       Impact factor: 28.824

8.  Induction of SOX4 by DNA damage is critical for p53 stabilization and function.

Authors:  Xin Pan; Jie Zhao; Wei-Na Zhang; Hui-Yan Li; Rui Mu; Tao Zhou; Hai-Ying Zhang; Wei-Li Gong; Ming Yu; Jiang-Hong Man; Pei-Jing Zhang; Ai-Ling Li; Xue-Min Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-20       Impact factor: 11.205

9.  LNCaP Atlas: gene expression associated with in vivo progression to castration-recurrent prostate cancer.

Authors:  Tammy L Romanuik; Gang Wang; Olena Morozova; Allen Delaney; Marco A Marra; Marianne D Sadar
Journal:  BMC Med Genomics       Date:  2010-09-24       Impact factor: 3.063

10.  Phosphorylation-triggered CUEDC2 degradation promotes UV-induced G1 arrest through APC/C(Cdh1) regulation.

Authors:  Wei-Na Zhang; Jie Zhou; Tao Zhou; Ai-Ling Li; Na Wang; Jin-Jing Xu; Yan Chang; Jiang-Hong Man; Xin Pan; Tao Li; Wei-Hua Li; Rui Mu; Bing Liang; Liang Chen; Bao-Feng Jin; Qing Xia; Wei-Li Gong; Xue-Min Zhang; Li Wang; Hui-Yan Li
Journal:  Proc Natl Acad Sci U S A       Date:  2013-06-17       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.